低剂量环磷酰胺联合氟达拉滨及抗胸腺细胞球蛋白作为再生障碍性贫血异基因造血干细胞移植的预处理方案 - Suppr

Reduced-dose cyclophosphamide in combination with fludarabine and anti-thymocyte globulin as a conditioning regimen for allogeneic hematopoietic stem cell transplantation for aplastic anemia.

作者信息

Kohashi Sumiko, Mori Takehiko, Hashida Risa, Kato Jun, Saburi Masuho, Kikuchi Taku, Koda Yuya, Toyama Takaaki, Yamane Yusuke, Yamanaka Satomi, Okamoto Shinichiro

机构信息

Division of Hematology, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.

出版信息

Int J Hematol. 2015 Jan;101(1):102-5. doi: 10.1007/s12185-014-1697-5. Epub 2014 Nov 9.

DOI:10.1007/s12185-014-1697-5

PMID:25381590

Abstract

摘要

相似文献

Reduced-dose cyclophosphamide in combination with fludarabine and anti-thymocyte globulin as a conditioning regimen for allogeneic hematopoietic stem cell transplantation for aplastic anemia.

Int J Hematol. 2015 Jan;101(1):102-5. doi: 10.1007/s12185-014-1697-5. Epub 2014 Nov 9.

A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia.

Int J Hematol. 2014 Mar;99(3):311-7. doi: 10.1007/s12185-014-1501-6. Epub 2014 Feb 1.

A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome.

Ann Hematol. 2012 Sep;91(9):1459-69. doi: 10.1007/s00277-012-1462-x. Epub 2012 Apr 18.

Alternative donor marrow transplantation in children with aplastic anemia using low-dose irradiation and fludarabine-based conditioning.

Bone Marrow Transplant. 2011 Aug;46(8):1148-50. doi: 10.1038/bmt.2010.241. Epub 2010 Oct 18.

Less could be better: the case for reducing the dose of cyclophosphamide for children undergoing allogeneic stem cell transplant for severe aplastic anemia.

Pediatr Transplant. 2013 Jun;17(4):326-7. doi: 10.1111/petr.12088. Epub 2013 Apr 14.

Allogeneic hematopoietic cell transplantation without total body irradiation from unrelated donor in adult patients with idiopathic aplastic anemia: fludarabine versus cyclophosphamide-ATG.

Leuk Res. 2014 Jul;38(7):730-6. doi: 10.1016/j.leukres.2014.01.002. Epub 2014 Jan 10.

Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia.

Pediatr Transplant. 2013 Jun;17(4):387-93. doi: 10.1111/petr.12073. Epub 2013 Apr 3.

Haploidentical haematopoietic stem cell transplantation using CD3 or CD3/CD19 depletion and conditioning with fludarabine, cyclophosphamide and antithymocyte globulin for acquired severe aplastic anaemia.

Br J Haematol. 2012 Apr;157(1):139-42. doi: 10.1111/j.1365-2141.2011.08924.x. Epub 2011 Nov 5.

Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party.

Bone Marrow Transplant. 2005 Dec;36(11):947-50. doi: 10.1038/sj.bmt.1705165.

Improved Outcome of a Reduced Toxicity-Fludarabine, Cyclophosphamide, plus Antithymocyte Globulin Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia: Comparison of 2 Multicenter Prospective Studies.

Biol Blood Marrow Transplant. 2016 Aug;22(8):1455-1459. doi: 10.1016/j.bbmt.2016.04.003. Epub 2016 May 8.

引用本文的文献

Pharmacokinetics of anti-thymocyte globulin in a patient with severe aplastic anemia treated with allogeneic bone marrow transplantation from a matched unrelated donor.

Blood Cell Ther. 2020 Dec 28;4(1):15-19. doi: 10.31547/bct-2020-012. eCollection 2021 Feb 25.

Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling.

Int J Hematol. 2016 Apr;103(4):461-8. doi: 10.1007/s12185-016-1960-z. Epub 2016 Feb 24.

本文引用的文献

A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia.

Int J Hematol. 2014 Mar;99(3):311-7. doi: 10.1007/s12185-014-1501-6. Epub 2014 Feb 1.

Allogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia.

Int J Hematol. 2013 May;97(5):573-80. doi: 10.1007/s12185-013-1333-9. Epub 2013 Apr 30.

Guest editorial: advances in the management of acquired aplastic anemia.

Int J Hematol. 2013 May;97(5):551-2. doi: 10.1007/s12185-013-1325-9. Epub 2013 Apr 21.

In vivo T-cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: Combined results of two studies on aplastic anemia and HLA-mismatched haploidentical transplantation.

Am J Hematol. 2013 Apr;88(4):294-300. doi: 10.1002/ajh.23392. Epub 2013 Feb 28.

Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party.

Haematologica. 2010 Jun;95(6):976-82. doi: 10.3324/haematol.2009.018267. Epub 2010 May 21.

Cytomegalovirus infection/disease after hematopoietic stem cell transplantation.

Int J Hematol. 2010 May;91(4):588-95. doi: 10.1007/s12185-010-0569-x. Epub 2010 Apr 23.

Fludarabine, cyclophosphamide, anti-thymocyteglobulin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function.

Am J Hematol. 2009 Mar;84(3):167-9. doi: 10.1002/ajh.21355.

Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine-based preparative regimen.

Br J Haematol. 2006 Jun;133(6):649-54. doi: 10.1111/j.1365-2141.2006.06084.x.

Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation.

Br J Haematol. 2006 May;133(3):305-14. doi: 10.1111/j.1365-2141.2006.06019.x.

Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party.

Bone Marrow Transplant. 2005 Dec;36(11):947-50. doi: 10.1038/sj.bmt.1705165.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Reduced-dose cyclophosphamide in combination with fludarabine and anti-thymocyte globulin as a conditioning regimen for allogeneic hematopoietic stem cell transplantation for aplastic anemia.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献